StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
BMO Capital Starts Abbvie (ABBV) at Outperform; Well-Positioned to Manage Humira's LOE
November 18, 2020 4:01 AM
(Updated - November 18, 2020 6:54 AM EST)BMO Capital analyst Gary Nachman initiates coverage on Abbvie (NYSE: ABBV) with an ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
New Coverage